Risk factors for developing endometrial cancer after benign endometrial sampling.
Risk factors for developing endometrial cancer after benign endometrial sampling.
复制标题
DOI:
10.1097/aog.0b013e31826b9fef
复制
发表时间:
2012-11
影响因子:
7.2
通讯作者:
Mariani A
中科院分区:
文献类型:
--
作者:
Torres ML;Weaver AL;Kumar S;Uccella S;Famuyide AO;Cliby WA;Dowdy SC;Gostout BS;Mariani A
To identify risk factors for endometrial cancer after benign results of endometrial biopsy or dilatation and curettage (D&C). Nested case-control study from Rochester Epidemiology Project data. Among 370 Olmsted County, Minnesota, residents who received an endometrial cancer diagnosis between 1970 and 2008, we identified 90 patients (24.5%) who had previous benign endometrial biopsy or D&C results (no atypical hyperplasia). We compared them with 172 matched controls who had benign endometrial biopsy or D&C results without subsequent endometrial cancer. Using a multivariable, conditional logistic regression model, we found that oral contraceptive use was protective (odds ratio [OR], 0.18; 95% confidence interval [CI], 0.08-0.45; P<.001), and personal history of colorectal cancer (OR, 4.44; 95% CI, 1.02-19.31; P<.05), endometrial polyp (OR, 4.12; 95% CI, 1.40-12.17; P=.01), and morbid obesity (OR, 3.40; 95% CI, 1.18-9.78; P<.03) were independently associated with subsequent endometrial cancer. Compared with the presence of no risk factor, presence of one and two or more risk factors increased the risk of endometrial cancer by 8.12 (95% CI, 3.08-21.44) and 17.87 (95% CI, 5.57-57.39) times, respectively. Assuming a 2.6% lifetime risk of EC, OR’s of 8.12 and 17.87 for 1 and 2 or more of the 4 afore-mentioned risk factors confer a lifetime risk of approximately 18% and 32%, respectively. One-fourth of patients with endometrial cancer had previous benign endometrial biopsy or D&C results. Personal history of colorectal cancer, presence of endometrial polyps, and morbid obesity are the strongest risk factors for having endometrial cancer after a benign endometrial biopsy or D&C result, and oral contraceptive use is the strongest protective factor.
登录
查看更多内容
影响因子:
168.9
作者:
Renehan, Andrew G.;Tyson, Margaret;Zwahlen, Marcel
通讯作者:
Zwahlen, Marcel
影响因子:
158.5
作者:
Hampel, H;Frankel, WL;Papadopoulos, N
通讯作者:
Papadopoulos, N
影响因子:
6.2
作者:
Zaino, RJ;Kauderer, J;Gallup, DG
通讯作者:
Gallup, DG
影响因子:
45.3
作者:
Zighelboim, Israel;Goodfellow, Paul J.;Mutch, David G.
通讯作者:
Mutch, David G.
影响因子:
4.7
作者:
Leitao, Mario M., Jr.;Kehoe, Siobhan;Abu-Rustum, Nadeern R.
通讯作者:
Abu-Rustum, Nadeern R.